Page 4 of 7
Table 1
Subjects anthropometric data in 3 stages of the study (n = 15).
Indicators At the start 6 weeks 12 weeks
Weight (kg) 68 ± 7.5* 68 ± 7.6 68 ± 7.8
BMI (kg/m2) 27.4 ± 3** 27.4 ± 3 27.4 ± 3
* Mean ± SD
** Mean height was 157.2 ± 7.2.

 

Table 2
Subjects mean food intake in 3 stages of the study (n = 15).
Variables at the start 6 weeks 12 weeks P value**
Energy (kcal) 1933.4 ± 302.5* 2033.2 ± 420.3 1902.8 ± 308.6 NS***
Protein (g) 74.6 ± 12.3 71.9 ± 17.4 74.8 ± 10.2 NS
Calcium (mg) 999.3 ± 460.2 966.8 ± 443.7 1014 ± 436 NS
Phosphore (mg) 873.2 ± 228.9 853.1 ± 273.9 866.4 ± 200.6 NS
* Mean ± SD
** significant level was set at below 5 percent (P < 0.05).
*** To analyze changes in 3 stages, repeated measurement analysis was utilized.

 

Table 3
Bone metabolism biomarkers in 3 stages of the study (n = 15).
Variables* At the start 6 weeks 12 weeks P value†
TALP (IU/l) 237.5 ± 85.4** 300.4 ± 294.1 281.3 ± 80.5 <0.05
OC (ng/ml) 11.4 ± 4.8 12.7 ± 5.7 11.5 ± 4.8 NS††
IGFBP3 (ng/ml) 3304.6 ± 728.6 3221.6 ± 534.4 3103.9 ± 639.8 NS
DPD (nmol/mmol) 7 ± 1.2 5.9 ± 1.1 5.1 ± 2.1 <0.05
C-TX (ng/ml) 0.79 ± 0.49 0.8 ± 0.4 0.8 ± 0.3 NS
ITCP (μg/l) 4.6 ± 0.9 4.3 ± 0.9 5.9 ± 1.1 NS

* TALP: Total alkaline phosphatase (IU/l); OC: Osteocalcin (ng/ml); IGFBP3: Insulin like growth factor binding protein 3 (ng/ml); DPD: Deoxypyridinoline (nmol/mmol); C-TX: C-Telopeptides (ng/ml); ITCP: Carboxy terminal telopeptides of type I collagen (μg/l)
** Mean ± SD
† To analyze changes in 3 stages, repeated measurement analysis was utilized.
†† significant level was set at below 5 percent (P < 0.05).